These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 24584782)
21. The proteasome inhibitor MG132 induces apoptosis in human pancreatic cancer cells. Wente MN; Eibl G; Reber HA; Friess H; Büchler MW; Hines OJ Oncol Rep; 2005 Dec; 14(6):1635-8. PubMed ID: 16273269 [TBL] [Abstract][Full Text] [Related]
22. Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice. Sugase T; Takahashi T; Serada S; Nakatsuka R; Fujimoto M; Ohkawara T; Hara H; Nishigaki T; Tanaka K; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Kishimoto T; Mori M; Doki Y; Naka T Int J Cancer; 2017 Jun; 140(11):2608-2621. PubMed ID: 28233302 [TBL] [Abstract][Full Text] [Related]
23. Comparison of the effect of p65 siRNA and curcumin in promoting apoptosis in esophageal squamous cell carcinoma cells and in nude mice. Tian F; Zhang C; Tian W; Jiang Y; Zhang X Oncol Rep; 2012 Jul; 28(1):232-40. PubMed ID: 22552693 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of autophagy by 3-MA potentiates cisplatin-induced apoptosis in esophageal squamous cell carcinoma cells. Liu D; Yang Y; Liu Q; Wang J Med Oncol; 2011 Mar; 28(1):105-11. PubMed ID: 20041317 [TBL] [Abstract][Full Text] [Related]
25. Tumor-associated macrophage (TAM)-secreted CCL22 confers cisplatin resistance of esophageal squamous cell carcinoma (ESCC) cells via regulating the activity of diacylglycerol kinase α (DGKα)/NOX4 axis. Chen J; Zhao D; Zhang L; Zhang J; Xiao Y; Wu Q; Wang Y; Zhan Q Drug Resist Updat; 2024 Mar; 73():101055. PubMed ID: 38387281 [TBL] [Abstract][Full Text] [Related]
26. Corilagin Inhibits Esophageal Squamous Cell Carcinoma by Inducing DNA Damage and Down-Regulation of RNF8. Qiu F; Liu L; Lin Y; Yang Z; Qiu F Anticancer Agents Med Chem; 2019; 19(8):1021-1028. PubMed ID: 30848215 [TBL] [Abstract][Full Text] [Related]
27. Isoalantolactone Inhibits Esophageal Squamous Cell Carcinoma Growth Through Downregulation of MicroRNA-21 and Derepression of PDCD4. Wen SW; Zhang YF; Li Y; Xu YZ; Li ZH; Lü H; Zhu YG; Liu ZX; Tian ZQ Dig Dis Sci; 2018 Sep; 63(9):2285-2293. PubMed ID: 29781054 [TBL] [Abstract][Full Text] [Related]
28. Proteasome inhibitor MG132 induces thyroid cancer cell apoptosis by modulating the activity of transcription factor FOXO3a. Qiang W; Sui F; Ma J; Li X; Ren X; Shao Y; Liu J; Guan H; Shi B; Hou P Endocrine; 2017 Apr; 56(1):98-108. PubMed ID: 28220348 [TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4. Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565 [TBL] [Abstract][Full Text] [Related]
30. Ivermectin suppresses tumour growth and metastasis through degradation of PAK1 in oesophageal squamous cell carcinoma. Chen L; Bi S; Wei Q; Zhao Z; Wang C; Xie S J Cell Mol Med; 2020 May; 24(9):5387-5401. PubMed ID: 32237037 [TBL] [Abstract][Full Text] [Related]
31. RUNX3 reverses cisplatin resistance in esophageal squamous cell carcinoma via suppression of the protein kinase B pathway. Li DJ; Shi M; Wang Z Thorac Cancer; 2016 Sep; 7(5):570-580. PubMed ID: 27766776 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of proteasome function induced apoptosis in gastric cancer. Fan XM; Wong BC; Wang WP; Zhou XM; Cho CH; Yuen ST; Leung SY; Lin MC; Kung HF; Lam SK Int J Cancer; 2001 Aug; 93(4):481-8. PubMed ID: 11477551 [TBL] [Abstract][Full Text] [Related]
33. Effect of hOGG1 over-expression on cisplatin resistance in esophageal squamous carcinoma cells. Gao D; Hu J; Zhang X; Gao C; Hong J Cancer Biother Radiopharm; 2013; 28(6):433-40. PubMed ID: 23806019 [TBL] [Abstract][Full Text] [Related]
34. Plumbagin, a natural naphthoquinone, inhibits the growth of esophageal squamous cell carcinoma cells through inactivation of STAT3. Cao Y; Yin X; Jia Y; Liu B; Wu S; Shang M Int J Mol Med; 2018 Sep; 42(3):1569-1576. PubMed ID: 29901084 [TBL] [Abstract][Full Text] [Related]
35. Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma. Lam SK; Leung LL; Li YY; Zheng CY; Ho JC Lung Cancer; 2016 Nov; 101():111-119. PubMed ID: 27794399 [TBL] [Abstract][Full Text] [Related]
36. Antitumor activity of Lobaplatin against esophageal squamous cell carcinoma through caspase-dependent apoptosis and increasing the Bax/Bcl-2 ratio. Du L; Fei Z; Song S; Wei N Biomed Pharmacother; 2017 Nov; 95():447-452. PubMed ID: 28865364 [TBL] [Abstract][Full Text] [Related]
37. Molecular mechanism of epigallocatechin-3-gallate in human esophageal squamous cell carcinoma in vitro and in vivo. Liu L; Hou L; Gu S; Zuo X; Meng D; Luo M; Zhang X; Huang S; Zhao X Oncol Rep; 2015 Jan; 33(1):297-303. PubMed ID: 25333353 [TBL] [Abstract][Full Text] [Related]
38. Knockdown of frizzled-7 inhibits cell growth and metastasis and promotes chemosensitivity of esophageal squamous cell carcinoma cells by inhibiting Wnt signaling. Liu X; Yan Y; Ma W; Wu S Biochem Biophys Res Commun; 2017 Aug; 490(3):1112-1118. PubMed ID: 28669726 [TBL] [Abstract][Full Text] [Related]
39. PRIMA-1 induces p53-mediated apoptosis by upregulating Noxa in esophageal squamous cell carcinoma with TP53 missense mutation. Furukawa H; Makino T; Yamasaki M; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y Cancer Sci; 2018 Feb; 109(2):412-421. PubMed ID: 29168598 [TBL] [Abstract][Full Text] [Related]
40. XPD inhibits cell growth and invasion and enhances chemosensitivity in esophageal squamous cell carcinoma by regulating the PI3K/AKT signaling pathway. Jian J; Li S; Liu LZ; Zhen L; Yao L; Gan LH; Huang YQ; Fang N Int J Mol Med; 2020 Jul; 46(1):201-210. PubMed ID: 32377720 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]